MAP2K7 and neoplasm: The two patients died 7 and 7.5 month after initial diagnosis of GBM.<h4>Conclusions</h4>Primary treatment with inhibitors of BRAF and MEK can lead to tumor regression for patients with <i>BRAF</i> <sup>V600E</sup> mutant glioblastoma.